Sign in

CIK 0000899923 · Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870494517
Phone
801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Shares withheld for taxes Chief Commercial Officer gave up 3,686 shares (to pay taxes)
  2. 4 Grant or award Chief Operating Officer acquired 64,494 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 46,095 shares (grant or award)
  4. 4 Shares withheld for taxes President and CEO gave up 30,610 shares (to pay taxes)
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Shares withheld for taxes Chief People Officer gave up 1,108 shares (to pay taxes)
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 4 Shares withheld for taxes Chief Technology Officer gave up 881 shares (to pay taxes)
  10. 4 Shares withheld for taxes SVP, Chief of Staff gave up 2,231 shares (to pay taxes)
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Grant or award Chief Financial Officer acquired 117,770 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 14 of 104 · 2,077 filings